PTI Insider Trading Activity and SEC Form 4 Filings
PTI insider trading summary
No open-market insider purchases or sales of Proteostasis Therapeutics, Inc. (PTI) have been reported on SEC Form 4 in the past 12 months.
Latest PTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 27, 2019 | Nea 12 Gp, LLC | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | Peter J Barris | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | Forest Baskett | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | New Enterprise Associates 12, Limited Partnership | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | Patrick J Kerins | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | NEA Partners 12, Limited Partnership | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 27, 2019 | Scott D Sandell | 10% Owner | Sell | $2.9M (1,166,755 @ $2.52) |
| Nov 26, 2019 | NEA Partners 12, Limited Partnership | 10% Owner | Sell | $287K (117,164 @ $2.45) |
| Nov 26, 2019 | Nea 12 Gp, LLC | 10% Owner | Sell | $287K (117,164 @ $2.45) |
| Nov 26, 2019 | Scott D Sandell | 10% Owner | Sell | $287K (117,164 @ $2.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.